Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis
出版年份 2015 全文链接
标题
Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis
作者
关键词
Optical Coherence Tomography, Ranibizumab, Well Correct Visual Acuity, Aflibercept, Early Treatment Diabetic Retinopathy Study
出版物
BMC Ophthalmology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-08-19
DOI
10.1186/s12886-015-0101-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration
- (2014) Wyatt B Messenger et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
- (2014) D S Grewal et al. EYE
- Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
- (2014) Heidi Fassnacht-Riederle et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
- (2013) Stephen S. Johnston et al. ADVANCES IN THERAPY
- Conversion to Aflibercept For Chronic Refractory Or Recurrent Neovascular Age-Related Macular Degeneration
- (2013) Yoshihiro Yonekawa et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-Term Outcomes of Aflibercept for Neovascular Age-Related Macular Degeneration in Eyes Previously Treated With Other Vascular Endothelial Growth Factor Inhibitors
- (2013) Vincent Y. Ho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
- (2013) Benjamin Bakall et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
- (2013) K H Patel et al. EYE
- Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
- (2013) Florian M. Heussen et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Nishant Kumar et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
- (2011) Maria Salling Eghøj et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2009) FARZIN FOROOGHIAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Predicted biological activity of intravitreal VEGF Trap
- (2008) M W Stewart et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
- (2008) Shlomit Schaal et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
- (2008) Salvatore Grisanti et al. PROGRESS IN RETINAL AND EYE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More